General Slide - Hero Slider

IASLC Statement on Upcoming 2021 Events

Updated October 16, 2020
JTO Hero Slider.jpg

JTO Impact Factor Increases to 13.357

JTO Impact Factor Increases from 12.460 to 13.357!
North America_hero slider

IASLC 2020 North America Conference on Lung Cancer

Oct 16, 2020 to Oct 17, 2020 Worldwide Virtual Event
IASLC Statement on Upcoming 2021 Events
JTO Impact Factor Increases to 13.357
IASLC 2020 North America Conference on Lung Cancer

Homepage

The International Association for the Study of Lung Cancer

The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's members—consisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregivers—are raising the bar for care of patients with lung cancer.

Explore More

In Focus

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

See More

Our Work

The IASLC Staging Project

The IASLC Staging Project is a global effort to study and improve the current staging system for lung cancer, mesothelioma, thymic and esophageal cancer.

Lung Ambition Alliance

The IASLC has formed an alliance with three other founding organizations to allow scientists, specialists, advocates, and patients to break the barriers limiting progress and double 5-year survival rates of lung cancer by 2025.

In Numbers

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
45
Years Experience
15K
Number of Research Awards Funded
13.357
JTO Impact Factor
8K+
Members

Upcoming Meetings & Webinars

IASLC Meeting
Jan 28 - Jan 31 2021
CME Accredited
IASLC Meeting
Sep 11 - Sep 14 2021
CME Accredited
JTO-CRR_Hero-0820 - Cropped.jpg

Journal of Thoracic Oncology & JTO Clinical and Research Reports

Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. JTO CRR, the official open access journal of the IASLC, complements the JTO by offering authors a gold open access publication option.